SPPI - Spectrum Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
Total Revenue
109,333
Cost of Revenue
-
Gross Profit
-
Operating Expenses
Research Development
103,864
Selling General and Administrative
90,875
Total Operating Expenses
222,837
Operating Income or Loss
-140,260
Interest Expense
-
Total Other Income/Expenses Net
-54,519
Income Before Tax
-192,090
Income Tax Expense
-7,755
Income from Continuing Operations
-184,335
Net Income
-165,487
Net Income available to common shareholders
-165,487
Reported EPS
Basic
-
Diluted
-
Weighted average shares outstanding
Basic
-
Diluted
-
EBITDA
-